CDH2 and lung cancer: In contrast, we found that fucoidan enhances the expression of E-cadherin but reduces the expression of N-cadherin and Vimentin at 24 and 48 h in CL1-5 cells in a dose-dependent manner (data not shown), suggesting that fucoidan inhibits cell mobility and alters the EMT in lung cancer cells.